Emmes is dedicating a center to enhance the company’s legacy and depth in cell and gene therapy research.
The company, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, noted in a news release that the center will focus on supporting the clinical trials of our clients who are developing cell and gene therapies around the world and across multiple therapeutic areas, including ophthalmology and rare diseases.
{iframe}https://www.ophthalmologytimes.com/view/emmes-launches-cell-and-gene-therapy-center{/iframe}